Results 211 to 220 of about 9,765 (234)
Some of the next articles are maybe not open access.
Trends in kinase drug discovery: targets, indications and inhibitor design
Nature Reviews Drug Discovery, 2021Misty M Attwood, Stefan Knapp
exaly
HCV NS5A Inhibitors: The Devil Is in the Details
Gastroenterology, 2014Menashe, Elazar, Jeffrey S, Glenn
openaire +2 more sources
O059 : Long-term persistence of HCV NS5A variants after treatment with NS5A inhibitor ledipasvir
Journal of Hepatology, 2015H. Dvory-Sobol +10 more
openaire +1 more source
Treatment of renal cell carcinoma: Current status and future directions
Ca-A Cancer Journal for Clinicians, 2017Pedro Coelho Barata, Brian I Rini
exaly
Lung cancer: New biological insights and recent therapeutic advances
Ca-A Cancer Journal for Clinicians, 2011Suresh S Ramalingam, Fadlo R Khuri
exaly
Diphenylcarboxamides as Inhibitors of HCV Non-Structural Protein NS5a
Antiviral Research, 2010Malcolm Carter +15 more
openaire +1 more source
NTRK fusion-positive cancers and TRK inhibitor therapy
Nature Reviews Clinical Oncology, 2018Emiliano Cocco +2 more
exaly
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Nature Reviews Cancer, 2019Jonathan J Havel +2 more
exaly
The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy
Nature Reviews Cancer, 2008Ludger Hengst, Joyce M Slingerland
exaly